Multispecific yet truly natural antibodies

Helping the body to fight cancer

Multispecific yet truly natural antibodies

Our biotechnology company researches, develops, and manufactures bispecific antibodies for the treatment of malignant tumors. We redirect the patient´s own immune cells, especially macrophages, T-cells and natural killer cells, to attack cancer cells – helping the body to fight cancer
Who we are
Who we are

Long-term pharma experience meets academia

Our antibody development roots go deep

Our focus
Our focus

Multispecific yet natural

Helping the body to fight cancer

CD47 Dual targeting
Our Pipeline

Fully human bispecific antibodies for cancer treatment

Safe and selective blockade of CD47 on tumors

Looking into the future
Partner with us

Interested in working with LamKap Bio?

Beyond bispecific antibodies

previous arrow
next arrow